Adjusted odds ratios of skilled delivery and skilled delivery with MAMA kits with community-level variables added one by one (Binary remittance exposure). by Chelsea Ducille (21540080)

Establishment of cBu-1 BAC16 for the isolation of reactivated cell population. by Tomoki Inagaki (12903779)

Subjects:

A Model for MST1-mediated protection in liver fibrosis caused by <i>Schistosoma japonicum</i> infection. by Jianyang Li (461703)

Subjects:

The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in old... by Kaifang Meng (13848535)

Water Withdrawal and Consumption Trends for Thermoelectric-Power Plants in the Conterminous United States, 2008–2020 by Kenneth D. Skinner (22280459)

Trends of prevalence (A), incidence (B) deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years by sex and socio... by Kaifang Meng (13848535)

Downregulation of CD36 impaired phagocytic capacity and is associated with a proinflammatory phenotype of <i>Mst1</i> deficiency macrophages. by Jianyang Li (461703)

Subjects:

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Subjects:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Subjects:

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Subjects:

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Subjects:

Innovation, nightlights and a continuous measure of city size. by Saul Estrin (8629173)

Superimposition of the cephalometric tracings obtained before and after treatment of case with premolar tooth extraction. by Lijuan Liu (136685)

Subjects:

Superimposition of the cephalometric tracings obtained before and after treatment of case with mandibular third molar extraction. by Lijuan Liu (136685)

Subjects: